CADD-57. THE EFFICACY OF THERAPY WITH ABT-414, AN EGFR-TARGETING ADC, IS POTENTIALLY ALTERED BY HETEROZYGOUS DELETION OF THE ENDOCYTIC TRAFFICKING REGULATOR RBSN
Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi283-vi284
10.1093/neuonc/noy148.1182